Dhanya Ramachandran, Qianqian Mao, Dandan Liao, Maud Kamal, Peter Schürmann, Rieke Eisenblätter, Robert Geffers, Balazs Balint, Lolita Lecompte, Nicolas Servant, Linda Larbi Chérif, Constance Lamy, Sylvain Baulande, Patricia Legoix, Christophe Le Tourneau, Aurélien Latouche, Peter Hillemanns, Suzy Scholl, Thilo Dörk
The reverse transcriptase subunit of telomerase, TERT, is frequently activated in high-grade dysplasia and invasive cancers of the uterine cervix. Telomerase activation through hypomethylation of the TERT promoter holds promise as a biomarker for cervical cancer progression, however, specific CpG sites involved in cervical cancer risk remain to be fully defined. A recent genome-wide association study on cervical cancer identified genetic polymorphisms at 5p13.33 (close to TERT-CLPTM1L) but the underlying mechanisms are undetermined...
October 1, 2024: Molecular Carcinogenesis